CSS LLC’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

CSS LLC’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,204	Closed	-$1.61M	–	1238
2020 Q4	$1.61M	Buy	+12,204	New	+$1.08M	0.06%	230

CSS LLC's EIDX Position: Q1 2021 in Review

CSS LLC sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 12,204 shares — an estimated $1.61M sold.

CSS LLC first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $1.61M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

CSS LLC reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
CSS LLC sold 12,204 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $1.61M.
CSS LLC first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
CSS LLC's Eidos Therapeutics, Inc. Common Stock position peaked at $1.61M in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on CSS LLC's 13F filing for Q1 2021, filed 17 May 2021.